Table 4.
CTRL | LR | HR | |
---|---|---|---|
Nucleus Accummbens (Shell) | 113.9 ± 5.94 | 111.7 ± 5.94 | 111.3 ± 4.42 |
Nucleus Accummbens (Core) | 95.88 ± 3.95 | 94.20 ± 5.89 | 91.99 ± 4.32 |
Caudate Putamen | 142.9 ± 6.54 | 129.9 ± 5.40 | 142.5 ± 3.87 |
Amygdala | 259.7 ± 11.57 | 253.4 ± 11.39 | 234.6 ± 29.78 |
Hippocampus (CA1) | 514.5 ± 24.13 | 532.6 ± 15.99 | 536 ± 20.56 |
Hippocampus (CA2) | 522.4 ± 30.61 | 545.3 ± 17.40 | 543.9 ± 17.99 |
Hippocampus (CA3) | 478.6 ± 22.48 | 507.5 ± 21.23 | 513.1 ± 20.32 |
Hippocampus (gyrus dentatus) | 442.4 ± 18.1 | 431.7 ± 25.03 | 477.7 ± 23.09 |
Hypotalamus Lateral | 265.7 ± 10.04 | 279.2 ± 12.70 | 248.9 ± 36.86 |
Hypothalamus ventro-medial | 287.8 ± 24.71 | 287.4 ± 15.75 | 240.1 ± 37.94 |
Data are expressed as mean fmol/mg protein of [3H]CP55940 ± SEM (n = 6 per group). None brain regions analyzed by one-way ANOVA exhibited change in the CB1 receptor levels when comparing all three experimental groups.